scope:

PURPOSE.

Pursuant to the authority vested in the Secretary of Defense by sections 113 and 125 of title 10, United States Code (Reference (a)), this Directive:

Reissues DoD Directive (DoDD) 5160.5 (Reference (b)) under a new subject to update policy, roles, and responsibilities for research, development, and acquisition (RDA) activities associated with the CBDP.

Updates and assigns responsibilities and functions associated with RDA of chemical, biological, and radiological (CBR) defense (CBRD) materiel (medical defense and physical (non-medical) defense) required to support combating weapons of mass destruction (WMD) missions as set forth in Secretary of Defense National Military Strategy and DoDD 2060.02 (References (c) and (d)). Specifically, the CBDP develops and acquires a family of integrated and interoperable CBRD capabilities that protect the force and enable military forces to operate successfully in CBR environments.

Designates and defines the role of the Secretary of the Army as the DoD Executive Agent for the CBDP pursuant to sections 1522 and 1523 of title 50, United States Code (U.S.C.), and Under Secretary of Defense for Acquisition, Technology, and Logistics (USD(AT&L)) Memorandum (References (e) and (f)), and in accordance with DoDD 5101.1 (Reference (g)).

APPLICABILITY

This Directive applies to OSD, the Military Departments, the Office of the Chairman of the Joint Chiefs of Staff and the Joint Staff, the Combatant Commands, the Office of the Inspector General of the Department of Defense, the Defense Agencies, the DoD Field Activities, and all other organizational entities within the Department of Defense (hereafter referred to collectively as the "DoD Components").

Implementation of this Directive shall comply with Reference (f). Changes to organizational assignments, structure, and processes defined by Reference (f) shall be approved by the USD(AT&L) prior to implementation.